Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pituitary Diseases × Hydrocortisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Leukemia 23 Prostatic Neoplasms 19 Burkitt Lymphoma 13 Leukemia, Biphenotypic, Acute 11 Lymphoma 9 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Lymphoma, Non-Hodgkin 5 Recurrence 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Pancreatic Neoplasms 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell 3 Hodgkin Disease 3 Dendritic Cell Sarcoma, Interdigitating 3 Breast Neoplasms 3 Anemia, Refractory, with Excess of Blasts 3 Polycystic Ovary Syndrome 2 Pituitary Neoplasms 2 Obesity 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myelomonocytic, Chronic 2 Anemia, Refractory 2 Stomatitis 1 Stomach Neoplasms 1

Interventions

Mifepristone 3 Corlux 3 Thyrotropin-Releasing Hormone 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1 Radiotherapy 1 Radiomics 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 LY2940680 1 Ipilimumab 1 Hydrocortisone 1 Human Growth Hormone 1 Diazoxide 1 Dexmedetomidine 1 Dexamethasone 1 Biomarkers 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed

43 enrolled 8 charts

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡